As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.
9 Analysts have issued a NeuroBo Pharmaceuticals Inc forecast:
9 Analysts have issued a NeuroBo Pharmaceuticals Inc forecast:
Jun '25 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -20 -20 |
24%
24%
|
EBIT (Operating Income) EBIT | -20 -20 |
24%
24%
|
Net Profit | -18 -18 |
29%
29%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.
Head office | United States |
CEO | Hyung-Heon Kim |
Founded | 2014 |
Website | metaviatx.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.